In the BioHarmony Drug Report Database
Ethylestrenol
Maxibolin (ethylestrenol) is a small molecule pharmaceutical. Ethylestrenol was first approved as Maxibolin on 1982-01-01. It is used to treat anemia and osteoporosis in the USA. The pharmaceutical is active against androgen receptor.
Trade Name
|
Maxibolin |
|---|---|
Common Name
|
ethylestrenol |
ChEMBL ID
|
CHEMBL1200623 |
Indication
|
anemia, osteoporosis |
Drug Class
|
Estrogens |
Image (chem structure or protein)